- Home
- GVH vs AIDX Comparison
GVH vs AIDX Comparison
Compare GVH & AIDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | GVH | AIDX |
|---|---|---|
| Founded | 2016 | 2000 |
| Country | Australia | United States |
| Employees | N/A | N/A |
| Industry | | Precision Instruments |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.6M | 3.0M |
| IPO Year | 2023 | 2025 |
Fundamental Metrics
Financial Performance| Metric | GVH | AIDX |
|---|---|---|
| Price | $0.92 | $0.21 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 24.8K | ★ 129.2K |
| Earning Date | 07-14-2026 | 11-15-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 34.48 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $2,045,133.00 |
| Revenue This Year | $1.85 | $44.20 |
| Revenue Next Year | N/A | $95.73 |
| P/E Ratio | $0.74 | ★ N/A |
| Revenue Growth | N/A | ★ 16.71 |
| 52 Week Low | $0.77 | $0.23 |
| 52 Week High | $6.46 | $18.96 |
Technical Indicators
Market Signals| Indicator | GVH | AIDX |
|---|---|---|
| Relative Strength Index (RSI) | 43.57 | 23.28 |
| Support Level | $0.87 | N/A |
| Resistance Level | $1.13 | $0.69 |
| Average True Range (ATR) | 0.07 | 0.02 |
| MACD | 0.00 | -0.00 |
| Stochastic Oscillator | 46.95 | 0.37 |
Price Performance
Historical ComparisonAbout GVH Globavend Holdings Limited
Globavend Holdings Ltd is an e-commerce logistics provider, it provides integrated cross-border logistics services from Hong Kong to Australia and New Zealand, where it provides customers with a one-stop solution from parcel consolidation to air freight forwarding, customs clearance, on-carriage parcel transportation and delivery. It operates in logistics and freight forwarding industry, which involves the provision of services such as freight transport, freight forwarding, warehouse management, and distribution.
About AIDX 20/20 Biolabs Inc. Common Stock
20/20 Biolabs Inc is a commercial stage diagnostics company with the core mission of developing and commercializing clinical laboratory tests for early disease detection and prevention and associated software that is powered by machine learning and real-world data to improve diagnostic accuracy and clinical utility. The company offers two OneTest lab products; OneTest for Cancer that inludes primary MCED blood test and revenue source post-COVID and OneTest for Longevity that consists of inflammatory biomarkers.